Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 22 Mar 2024 · owen-0937
Quote
Not a forecast
“I have learned that when there is a best-selling drug, there is a federal case brought for illegal marketing. These cases are routinely settled by the DOJ for way, way less money than the drug made thanks to said illegal marketing.”
'The Federal Settlements' section of Abilify V. The author, as a self-described dilettante historian of pharmaceuticals, states a general pattern: every best-selling drug attracts a federal illegal-marketing case, and the DOJ routinely settles for far less than the drug earned; he adds that this may be a rational strategy for the companies. Illustrated by the 2007 $515m BMS settlement and the 2008 $4m Otsuka settlement over Abilify.
Descriptive, retrospective, or a statement of preference; no future state asserted.